Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00392691

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Completed

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

NCT00544219

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • European Institute of Oncology Milan, Italy
  • Hirslanden Klinik Aarau Aarau, Switzerland
  • Kantonspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
View all 19 locations
View Trial Details
Completed

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

NCT01539512

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • University of California, San Diego- Moores Cancer Center La Jolla, California, United States
  • Ventura County Hematology Oncology Specialists Oxnard, California, United States
View all 72 locations
View Trial Details
Completed

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

NCT02780167

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +18 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Huntington Medical Foundation Pasadena, California, United States
  • Peninsula Research Associates, Inc. Rolling Hills Estates, California, United States
View all 64 locations
View Trial Details

Related conditions